Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 5,463	$ 4,448	$ 10,288	$ 8,517
Cost of revenue (COR)	2,111	1,873	4,137	3,629
Gross profit	3,352	2,575	6,151	4,888
Research and development (R&D)	535	527	1,045	1,044
Selling, general and administrative (SG&A)	490	485	954	957
Acquisition charges	17	0	34	0
Operating profit	2,310	1,563	4,118	2,887
Other income (expense), net (OI&E)	69	48	116	128
Interest and debt expense	141	133	282	261
Income before income taxes	2,238	1,478	3,952	2,754
Provision for income taxes	258	183	427	280
Net income	$ 1,980	$ 1,295	$ 3,525	$ 2,474
Earnings per common share (EPS):
Basic (in dollars per share)	$ 2.16	$ 1.42	$ 3.85	$ 2.71
Diluted (in dollars per share)	$ 2.14	$ 1.41	$ 3.82	$ 2.69
Average shares outstanding:
Basic (in shares)	912	908	911	909
Diluted (in shares)	920	912	917	914
Diluted EPS:
Net income	$ 1,980	$ 1,295	$ 3,525	$ 2,474
Income allocated to RSUs	(11)	(7)	(20)	(13)
Income allocated to common stock for diluted EPS	$ 1,969	$ 1,288	$ 3,505	$ 2,461

Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net income	$ 3,525	$ 2,474
Adjustments to net income:
Depreciation	1,088	884
Amortization of capitalized software	42	41
Stock compensation	236	245
Gains on sales of assets	(13)	0
Deferred taxes	(66)	(137)
Increase (decrease) from changes in:
Accounts receivable	(557)	(215)
Inventories	199	(285)
Prepaid expenses and other current assets	(7)	(16)
Accounts payable and accrued expenses	(24)	(29)
Accrued compensation	(305)	(255)
Income taxes payable	116	61
Changes in funded status of retirement plans	7	(27)
Other	(18)	(32)
Cash flows from operating activities	4,223	2,709
Cash flows from investing activities
Capital expenditures	(1,190)	(2,428)
Proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives	1,104	260
Proceeds from asset sales	37	0
Purchases of short-term investments	(3,342)	(1,839)
Proceeds from short-term investments	1,679	3,938
Other	(37)	(13)
Cash flows from investing activities	(1,749)	(82)
Cash flows from financing activities
Proceeds from issuance of long-term debt	0	1,199
Repayment of debt	0	(750)
Dividends paid	(2,586)	(2,473)
Stock repurchases	(185)	(955)
Proceeds from common stock transactions	754	233
Other	(22)	(37)
Cash flows from financing activities	(2,039)	(2,783)
Net change in cash and cash equivalents	435	(156)
Cash and cash equivalents at beginning of period	3,225	3,200
Cash and cash equivalents at end of period	3,660	3,044
Supplemental cash flow information
Investment tax credit (ITC) used to reduce income taxes payable	301	203
Proceeds from CHIPS Act incentives	1,104	260
Total cash benefit related to the CHIPS Act	$ 1,405	$ 463

Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 3,660	$ 3,225
Short-term investments	3,341	1,656
Accounts receivable, net of allowances of ($22) and ($22)	2,520	1,963
Raw materials	467	465
Work in process	2,407	2,372
Finished goods	1,731	1,967
Inventories	4,605	4,804
Prepaid expenses and other current assets	1,631	2,102
Total current assets	15,757	13,750
Property, plant and equipment at cost	17,856	17,682
Accumulated depreciation	(5,945)	(5,362)
Property, plant and equipment	11,911	12,320
Goodwill	4,330	4,330
Deferred tax assets	1,017	967
Capitalized software licenses	314	238
Overfunded retirement plans	316	324
Other long-term assets	2,237	2,656
Total assets	35,882	34,585
Current liabilities:
Current portion of long-term debt	1,149	500
Accounts payable	680	756
Accrued compensation	536	829
Income taxes payable	70	67
Accrued expenses and other liabilities	809	1,007
Total current liabilities	3,244	3,159
Long-term debt	12,903	13,548
Underfunded retirement plans	123	124
Deferred tax liabilities	55	66
Other long-term liabilities	1,550	1,415
Total liabilities	17,875	18,312
Stockholders’ equity:
Preferred stock, $25 par value. Shares authorized – 10; none issued	0	0
Common stock, $1 par value. Shares authorized – 2,400; shares issued – 1,741	1,741	1,741
Paid-in capital	5,129	4,511
Retained earnings	53,161	52,236
Treasury common stock at cost Shares: June 30, 2026 – 828; December 31, 2025 – 834	(41,941)	(42,130)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(83)	(85)
Total stockholders’ equity	18,007	16,273
Total liabilities and stockholders’ equity	$ 35,882	$ 34,585